Prelude Capital Management’s uniQure QURE Stock Holding History

Prelude Capital Management’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$9K	–	2249
2020 Q2	$9K	Buy	+200	New	+$11.8K	﹤0.01%	1602

Other funds holding QURE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's QURE Position: Q1 2026 in Review

Prelude Capital Management sold out of uniQure (QURE) in Q1 2026, closing a stake of 15,739 shares — an estimated $377K sold.

Prelude Capital Management first reported a position in QURE in Q1 2015 and held it in 18 quarters. The position peaked at $710K in Q3 2025. 212 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Prelude Capital Management reported no remaining uniQure position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 15,739 uniQure shares in Q1 2026, an estimated $377K.
Prelude Capital Management first reported a position in uniQure in Q1 2015 and held it in 18 quarters.
Prelude Capital Management's uniQure position peaked at $710K in Q3 2025.
212 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.